Larotrectinib and Mesalamine Long-Acting Capsules (Apriso)
Determining the interaction of Larotrectinib and Mesalamine Long-Acting Capsules (Apriso) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: larotrectinib
Brand name: Vitrakvi
Synonyms: n.a.
Generic Name: mesalamine
Brand name: Apriso, Asacol HD, Delzicol, Lialda, Pentasa, Canasa, Canasa Pac, Rowasa, SfRowasa
Synonyms: Mesalamine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Larotrectinib-Mesalamine Long-Acting Capsules (Delzicol)
- Larotrectinib-Mesalamine Long-Acting Capsules (Pentasa)
- Larotrectinib-Mesalamine rectal
- Larotrectinib-Mesalamine Rectal Enema
- Larotrectinib-Mesalamine Rectal Suspension
- Larotrectinib-Mesalamine Suppositories
- Mesalamine Long-Acting Capsules (Apriso)-Larotrectinib Capsules
- Mesalamine Long-Acting Capsules (Apriso)-Larotrectinib Oral Solution
- Mesalamine Long-Acting Capsules (Apriso)-Larotrectinib Sulfate
- Mesalamine Long-Acting Capsules (Apriso)-Lartruvo
- Mesalamine Long-Acting Capsules (Apriso)-Larynex
- Mesalamine Long-Acting Capsules (Apriso)-Laryng-O-Jet